"BNP" for heart failure: role of nesiritide in cardiovascular therapeutics (Q34943458)

5 August 2017

1 reference

title

"BNP" for heart failure: role of nesiritide in cardiovascular therapeutics (English)

1 reference

5 August 2017

0 references

1 reference

Roger M Mills

1

1 reference

5 August 2017

Robert E Hobbs

series ordinal

2

1 reference

5 August 2017

James B Young

series ordinal

3

1 reference

5 August 2017

publication date

1 September 2002

1 reference

5 August 2017

published in

Congestive Heart Failure

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

270-273

1 reference

A new natriuretic peptide in porcine brain

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Molecular biology of the natriuretic peptides and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1527-5299.2002.01154.X

10.1111/J.1527-5299.2002.01154.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference